Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 132 for “"HDAC6"”.

  1. The Role of HDAC6 in Periodontal Inflammation

    … valuable treatment. Histone Deacetylase 6 (HDAC6) is an enzyme that removes acetyl groups from both histone and non-histone proteins, giving it a potential role in regulating inflammation initiated by pathogenic oral bacteria. Previous studies indicated that HDACs act as a bivalent regulator …

    vcu Repository record for The Role of HDAC6 in Periodontal Inflammation (opens in a new tab)

  2. Inhibition of HDAC6 attenuates progression of hypertension

    … Ⅱ를 투여하여 고혈압을 유도하고 Histone Deacetylase6 (HDAC6) 억제제를 투여하여 고혈압 완화효과를 확인하고자 하였다. Human Embryonic Kidney (HEK 293) 세포에서 Angiotensin Ⅱ를 처리하여 HDAC6 발현이 증가하였음을 확인하였고 Angiotensin Ⅱ와 HDAC6 억제제인 Tubastatin A로 처리하여 cystathionine gamma lyase (CSE) 발현이 증가하였다. HEK 293 세포와 Human aortic endothelial cell …

    ajou Repository record for Inhibition of HDAC6 attenuates progression of hypertension (opens in a new tab) Embargoed until 9999-12-31

  3. Selective HDAC6 Inhibition in Systemic Lupus Erythematosus

    … SLE with promising results, however selective HDAC6 inhibition (HDAC6i) has become a leading candidate for pharmacologic inhibition to reduce the potential for side effects. We hypothesize that HDAC6i will decrease SLE disease by targeting substrates of HDAC6 in multiple components of immunity …

    vt Repository record for Selective HDAC6 Inhibition in Systemic Lupus Erythematosus (opens in a new tab)

  4. Roles of Cytoplasmic Deacetylase Hdac6 in Oncogenic Tumorigenesis

    … growth.</p><p>In this thesis, I have showed that HDAC6, a cytoplasmic localized and cytoskeleton-associated deacetylase, is required for efficient oncogenic transformation and tumor formation. I have found that HDAC6 expression is induced upon oncogenic Ras-induced transformation in both human …

    duke Repository record for Roles of Cytoplasmic Deacetylase Hdac6 in Oncogenic Tumorigenesis (opens in a new tab)

  5. HDAC6 Deletion Decreases Pristane-Induced Inflammation and Lupus

    … 6 is a class IIb histone deacetylase member. HDAC6 has the ability to catalyze the removal of acetyl groups from lysine residues on non-histone proteins. It has been observed that in lupus mouse models, specific HDAC6 inhibition reduces inflammation. Administration of pristane, a naturally …

    vt Repository record for HDAC6 Deletion Decreases Pristane-Induced Inflammation and Lupus (opens in a new tab)

  6. Computational and Pharmacological Characterization of HDAC6 Inhibition and Function

    HDAC6 is a unique histone deacetylase. It contains two catalytic domains, of which they act independently or in tandem. It belongs to the class IIb HDACs and is Zn2+ dependant. It has been seen to be involved in various diseases such as diabetic neuropathies and certain cancers including breast …

    qu-belfast Repository record for Computational and Pharmacological Characterization of HDAC6 Inhibition and Function (opens in a new tab) Download PDF for Computational and Pharmacological Characterization of HDAC6 Inhibition and Function (opens in a new tab)

  7. Functional characterization of NEDD8 in HDAC6 and ubiquitin mediated signaling pathway

    … SNIPs)을 동정하였으며, 이를 통해 histone deacetylase 6(HDAC6) 및 BAG3 등과 같은 선택적 autophagy와 연관된 NEDD8 결합 단백질들을 동정하였다. 이들 중 HDAC6는 프리유비퀴틴체인의 수용체로써 세포 내 유비퀴틴화된 aggregate들의 분해를 유도하는 과정에서 aggresome의 형성에 관여하는 주요 단백질로 보고된 바 있다. 본 연구에서는 NEDD8이 HDAC6와의 특이적 상호작용을 통해 어떻게 세포 내 주요 신호 전달 과정에 관여하는지에 대한 연구를 진행하였다. …

    ajou Repository record for Functional characterization of NEDD8 in HDAC6 and ubiquitin mediated signaling pathway (opens in a new tab) Embargoed until 9999-12-31

  8. HDAC6 controls the development and progression of cardiac mal-adaptive hypertrophy

    … In particular, enzymatic activity of HDAC6 is strongly upregulated in different models of pressure-induced cardiac hypertrophy. Therefore, the effects of a general HDAC inhibitor (HDACi) Trichostatin A (TSA) and a HDAC6 specific inhibitor (HDAC6i) Tubacin were investigated in the …

    fu-berlin Repository record for HDAC6 controls the development and progression of cardiac mal-adaptive hypertrophy (opens in a new tab)

  9. The role of HDAC6 in the cellular contractility of metastatic cells

    … and cell structure. Histone deacetylase 6 (HDAC6) is an enzyme in humans and HDAC6 gene expression correlates with increased carcinogenesis and metastasis of cancer cells. Aim: To determine the effect of HDAC6 on contractile forces of metastasising human BJ fibroblasts and the molecular …

    whiterose Download PDF for The role of HDAC6 in the cellular contractility of metastatic cells (opens in a new tab)

  10. THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY

    … mitigated with the use of DOPE/CHEMS and HDAC6 inhibitors in a cationic-polymer based transfection workflow. As an extension, multiple-plasmid transfection was shown to be similarly enhanced, translating to higher lentivirus production. DOPE/CHEMS and SAHA also significantly enhanced …

    nus Repository record for THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY (opens in a new tab) Download file for THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY (opens in a new tab)

  11. Synthesis of thiaheterocyclic benzohydroxamic acids and evaluation of their HDAC6 inhibitory activity

    … effective and selective histone deacetylase 6 (HDAC6) inhibition. HDAC6 is a member of the broader histone deacetylases enzyme family, which regulate the folding of DNA around histones and thus indirectly influence transcription. A major drawback associated with non-selective HDAC inhibitors …

    ghent Repository record for Synthesis of thiaheterocyclic benzohydroxamic acids and evaluation of their HDAC6 inhibitory activity (opens in a new tab)

  12. Drug Discovery based on Oxidative Stress and HDAC6 for Treatment of Neurodegenerative Diseases

    … acid into the cap group of a tertiary amide HDAC6 inhibitor. Compound 10b was screened as the best hybrid molecule exhibit potent HDAC6 inhibition and potent antioxidant capacity. Compound 10b also alleviated LPS-induced microglia inflammation and led to a switch from neurotoxic M1 to the …

    wurz-thes Repository record for Drug Discovery based on Oxidative Stress and HDAC6 for Treatment of Neurodegenerative Diseases (opens in a new tab)

  13. Hdac6 Inhibition Reverses Long-Term Doxorubicin-Induced Cognitive Dysfunction By Restoring Microglia Homeostasis

    … barrier permeable histone deacetylase 6 (HDAC6) inhibitor successfully reverses long-term CICD following a therapeutic doxorubicin dosing schedule in female mice, as assessed by the puzzle box test and novel object/place recognition test. Long-term CICD was associated with a decreased …

    uthsc Repository record for Hdac6 Inhibition Reverses Long-Term Doxorubicin-Induced Cognitive Dysfunction By Restoring Microglia Homeostasis (opens in a new tab)

  14. Validation of HDAC6 and SIRT2 Tubulin Deacetylases as therapeutic targets for Huntington’s Disease.

    … disease modifying potential for both HDAC6 and SIRT2, which are the only tubulin deacetylases known in mammals. Nevertheless, the therapeutic value of these enzymes has not yet been explored in a complex mammalian system. This work addressed the question of what is the effect of …

    kings Repository record for Validation of HDAC6 and SIRT2 Tubulin Deacetylases as therapeutic targets for Huntington’s Disease. (opens in a new tab) Download PDF for Validation of HDAC6 and SIRT2 Tubulin Deacetylases as therapeutic targets for Huntington’s Disease. (opens in a new tab)

  15. Honokiol attenuates angiotensinⅡ-induced hypertensin by inhibiting HDAC6-mediated cystathionine γ-lyase degradation

    … studies the part of histone deacetylase 6 (HDAC6) in hypertension has been recommend, but the underlying mechanisms are poorly understood. We found that tubastatin A the HDAC6 inhibitor attenuates angiotensin II induced hypertension by preventing CSE protein degradation. Our results indicate …

    ajou Repository record for Honokiol attenuates angiotensinⅡ-induced hypertensin by inhibiting HDAC6-mediated cystathionine γ-lyase degradation (opens in a new tab) Embargoed until 9999-12-31

  16. HEDGEHOG/HDAC6 INHIBITION AND CHEMOTHERAPY: ASSESSMENT OF NEW DRUG COMBINATION IN ACUTE MYELOID LEUKEMIA

    … and most of them target the histone deacetylase HDAC6. Indeed, HDAC6 inhibition prevents the reabsorption of the PC and blocks cell proliferation. Since HDAC6 inhibitors (i.e., TubastatinA) are already used to treat other tumors, they might also be promising in AML treatment. In this work, …

    milano Repository record for HEDGEHOG/HDAC6 INHIBITION AND CHEMOTHERAPY: ASSESSMENT OF NEW DRUG COMBINATION IN ACUTE MYELOID LEUKEMIA (opens in a new tab)

Page 1 of 7